GlassScriptPhysician profile
Neil Malhotra
NPI 1043574338
$2,552.75
in general payments reported to CMS, 2019-2025
36 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $631 · 2020: $405 · 2021: $267 · 2022: $370 · 2023: $359 · 2024: $188 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $880.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $879.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $543.33 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Nevro Corp. | $234.98 | 2019-2024 | Senza |
| Abbott Laboratories | $194.79 | 2019-2025 | Proclaim, Octrode |
| Pacira Therapeutics, INC. | $136.58 | 2019-2021 | |
| Electronic Waveform Lab, INC. | $126.81 | 2022 | |
| Collegium Pharmaceutical, INC. | $122.45 | 2020-2025 | Belbuca |
| Pfizer INC. | $93.99 | 2019-2021 | |
| Redhill Biopharma INC. | $82.74 | 2020 | |
| Allergan, INC. | $76.61 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $75.93 | 2022-2025 | Zilretta, Iovera |
| Abbvie INC. | $72.07 | 2022-2023 | |
| Fidia Pharma USA INC. | $68.28 | 2019-2022 | |
| Si-Bone, INC. | $63.24 | 2019 | |
| Depuy Synthes Sales INC. | $60.37 | 2019-2025 | Orthovisc, Monovisc |
| Spr Therapeutics, INC | $54.89 | 2023 | Sprint Pns System |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $47.62 | 2022-2023 | Genvisc 850 Sodium Hyaluronate |
| Foundation Fusion Solutions, LLC | $47.50 | 2024-2025 | |
| Vertos Medical, INC. | $45.20 | 2021-2023 | Mild Device Kit |
| Medtronic, INC. | $44.90 | 2023 | Intellis Adaptivestim |
| Valinor Pharma, LLC | $39.17 | 2025 | Movantik |
| Arbor Pharmaceuticals, INC. | $35.51 | 2019-2021 | |
| Medtronic USA, INC. | $29.00 | 2019-2020 | |
| Ge Healthcare | $28.43 | 2019 | |
| Relievant Medsystems, INC. | $25.00 | 2023 | Intracept |
| Globus Medical, INC. | $24.97 | 2025 | Senza |
| Orthogenrx INC. | $22.14 | 2019 | |
| Spinal Simplicity, LLC | $17.30 | 2023 | Ha Minuteman G3-R |
| Astrazeneca Pharmaceuticals LP | $17.26 | 2019 | |
| Scilex Pharmaceuticals INC. | $17.14 | 2019 | |
| Hikma Pharmaceuticals USA | $16.52 | 2022 | |
| Painteq LLC | $16.50 | 2021 | |
| Bioventus LLC | $15.12 | 2019 | |
| Azurity Pharmaceuticals, INC. | $15.02 | 2023 | Horizant |
| Siemens Medical Solutions USA, INC. | $14.17 | 2022 | |
| Stimwave Technologies Incorporated | $14.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Malhotra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.